HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael E Petrone Selected Research

Drug Therapy (Chemotherapy)

11/2009Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael E Petrone Research Topics

Disease

3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2018 - 01/2016
2Prostatic Neoplasms (Prostate Cancer)
11/2009 - 06/2009
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018
1Pain (Aches)
11/2009
1Neoplasms (Cancer)
06/2009
1Breast Diseases (Breast Disease)
06/2009

Drug/Important Bio-Agent (IBA)

2satraplatin (JM 216)IBA
11/2009 - 06/2009
1ON 01910IBA
01/2018
1PlatinumIBA
11/2009
1Prednisone (Sone)FDA LinkGeneric
11/2009
1Hormones (Hormone)IBA
06/2009

Therapy/Procedure

3Therapeutics
01/2018 - 01/2016
1Salvage Therapy
01/2016
1Drug Therapy (Chemotherapy)
11/2009